HIGHLIGHTS
- who: American Medical Association from the (UNIVERSITY) have published the paper: Cost-effectiveness of Prostate Cancer Screening Using Magnetic Resonance Imaging or Standard Biopsy Based on the STHLM3-MRI Study, in the Journal: (JOURNAL) of November/10,/2022
- what: This contrast exhibits an important difference by the study setting, where far fewer of the patients from a diagnostic setting, as per the Cochrane Review, had a negative MRI result compared with findings from a screening-by-invitation setting . The results from this trial provided level 1 evidence on the effectiveness of MRI and combined biopsy . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.